THYROTROPIN-RELEASING HORMONE (TRH) is capable of antagonising pentobarbital narcosis, and this effect is independent of its hypophysiotropic function1,2. The potency of intraventricular injections2,3 and the localisation of TRH in nerve terminals from both hypothalamic and extrahypothalamic sites4,5, suggest that TRH may function as a neuromodulator in the central nervous system (CNS)6. Although TRH antagonism of pentobarbital has been behaviourally and electroencephalographically7,8 characterised, the underlying neuroanatomical substrate remains unknown. In an attempt to identify the central substrate mediating this effect, we have used intracerebral microinjection of TRH into specific brain loci. Brain sites were chosen to represent large neuroanatomical regions—as cholinergic activation has been hypothesised to mediate pentobarbital antagonism by TRH, structures belonging to the cholinergic activating system9 were examined, and we also examined medially located brain regions that Wei et al.10 found to be most active at inducing TRH-mediated shaking. While a number of sites were found responsive at 500 ng of TRH, the septal region proved exceptionally sensitive by responding significantly at only 5.0 ng TRH.
Subscribe to Journal
Get full journal access for 1 year
only $3.90 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Breese, G. R. et al. J. Pharmac. exp. Ther. 193, 11–12 (1975).
Horita, A., Carino, M. A. & Chesnut, R. M. Psychopharmacology 49, 57–62 (1976).
Bissette, G. et al. Neuropharmacology 17, 229–237 (1978).
Winokur, A., Davis, R. & Utiger, R. D. Brain Res. 120, 423–434 (1977).
Winokur, A. & Utiger, R. D. Science 185, 265–267 (1974).
Brownstein, M. J., Palkovits, M., Saavedra, J. M., Bassiri, R. M. & Utiger, R. D. Science 185, 267–269 (1974).
Kalivas, P. W., Halpern, L. M. & Horita, A. Proc. West. Pharmac. Soc. 21, 443–446 (1978).
Beale, J. S., White, R. P. & Huang, S. Neuropharmacology 16, 499–506 (1977).
Schute, C. C. D. & Lewis, P. R. Brain 90, 497–540 (1967).
Wei, E., Sigel, S., Loh, H. & Way, E. L. Nature 253, 739–740 (1975).
Carino, M. A., Smith, J. R., Weick, B. G. & Horita, A. Life Sci. 19, 1687–1692 (1976).
Hökfelt, T., Fuxe, K., Johansson, O., Jeffcoate, S. & White, N. Eur. J. Pharmac. 34, 389–392 (1975).
Youngblood, W. W., Lipton, M. A. & Kizer, J. S. Brain Res. 151, 99–116 (1978).
Schaeffer, J. M., Axelrod, J. & Brownstein, M. J. Brain Res. 138, 571–574 (1977).
Winokur, A. & Beckman, A. L. Brain Res. 150, 205–209 (1978).
Burt, D. R. Neurosci. Abstr. 4, 406 (1978).
Yarbrough, G. G. Eur. J. Pharmac. 48, 19–27 (1978).
Cheney, D. L. & Costa, E. A. Rev. Pharmac. Toxic. 17, 369–386 (1977).
Schmidt, D. E. Commun. Psychopharmac. 1, 469–473 (1977).
Kuhar, M. F. The Hippocampus Vol. 1 (eds Isaacson, R. L. & Pribram, K. H.) (Plenum, New York, 1975).
Smith, C. M. Life Sci. 14, 2159–2166 (1974).
Szerb, J. C. J. Physiol., Lond. 192, 329–343 (1967).
Pellegrino, L. J. & Cushman, A. J. A Stereotaxic Atlas of the Rat Brain (Appleton–Century–Crofts, New York, 1967).
About this article
Cite this article
KALIVAS, P., HORITA, A. Thyrotropin-releasing hormone: central site of action in antagonism of pentobarbital narcosis. Nature 278, 461–463 (1979). https://doi.org/10.1038/278461a0
The effects of single and repeated morphine administration on the level of thyrotropin-releasing hormone and its receptors in the rat brain
Permeability of NS-3, a Thyrotropin-releasing Hormone Analogue, into the Brain After Its Systemic Administration in Rats: A Microdialysis Study
Journal of Pharmacy and Pharmacology (1995)
Molecular cloning and functional expression of a human thyrotropin-releasing hormone (TRH) receptor gene
Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression (1994)
The study of brain slices from hibernating mammals in vitro and some approaches to the analysis of hibernation problems in vivo
Progress in Neurobiology (1993)